Epstein-Barr virus infection and chronic lymphocytic leukemia: A possible progression factor?

Infectious Agents and Cancer

Volumn 5, Issue 1, 2010, Pages

  Dolcetti, Riccardo ^a   Carbone, Antonino ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; EPSTEIN BARR VIRUS INFECTION; HUMAN; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REVIEW; RICHTER SYNDROME;

EID: 78549290718     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-5-22     Document Type: Review

References (34)

1. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. MA Epstein BG Achong YM Barry, Lancet 1964 1 7335 702 703 10.1016/S0140-6736(64) 91524-7 14107961
2. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. EM Miyashita B Yang GJ Babcock DA Thorley-Lawson, J Virol 1997 71 7 4882 4891 9188550
3. EBV persistence in memory B cells in vivo. GJ Babcock LL Decker M Volk DA Thorley-Lawson, Immunity 1998 9 3 395 404 10.1016/S1074-7613(00)80622-6 9768759
4. Epstein-Barr virus: induction and control of cell transformation. R Dolcetti MG Masucci, J Cell Physiol 2003 196 2 207 218 10.1002/jcp.10263 12811813
5. SH Swerdlow E Campo NL Harris, et al. WHO Classification of tumours of Haematopoietic and lymphoid tissues IARC Press, Lyon, France 2008
6. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. MN Richter, Am J Pathol: 1928 IV 4 285 292
7. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. B Timar Z Fulop B Csernus C Angster A Bognar A Szepesi L Kopper A Matolcsy, Leukemia 2004 18 2 326 330 10.1038/sj.leu.2403249 14671632
8. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Z Mao L Quintanilla-Martinez M Raffeld M Richter J Krugmann C Burek E Hartmann T Rudiger ES Jaffe HK Muller-Hermelink G Ott F Fend A Rosenwald, Am J Surg Pathol 2007 31 10 1605 1614 10.1097/PAS.0b013e31804bdaf8 17895764
9. Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle. N Teramoto P Gogolak N Nagy A Maeda K Kvarnung T Bjorkholm E Klein, J Hum Virol 2000 3 3 125 136 10881992
10. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. V Wendel-Hansen J Sallstrom PO De Campos-Lima G Kjellstrom A Sandlund A Siegbahn M Carlsson K Nilsson A Rosen, Leukemia 1994 8 3 476 484 8127151
11. Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins. A Maeda K Bandobashi N Nagy N Teramoto P Gogolak K Pokrovskaja L Szekely M Bjorkholm G Klein E Klein, J Hum Virol 2001 4 5 227 237 11907380
12. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells. CE Bueso-Ramos A Ferrajoli LJ Medeiros MJ Keating Z Estrov, Hematology 2004 9 4 279 286 10.1080/10245330410001727046 15621735
13. Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study. AM Tsimberidou MJ Keating CE Bueso-Ramos R Kurzrock, Leuk Lymphoma 2006 47 5 827 836 10.1080/10428190500398856 16753866
14. Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience. AM Tsimberidou S O'Brien HM Kantarjian C Koller FB Hagemeister L Fayad S Lerner CE Bueso-Ramos MJ Keating, Cancer 2006 107 6 1294 1302 10.1002/cncr.22121 16902984
15. Epstein-Barr virus infection in Richter's transformation. SM Ansell CY Li RV Lloyd RL Phyliky, Am J Hematol 1999 60 2 99 104 10.1002/(SICI)1096- 8652(199902)60:2<99::AID-AJH3>3.0.CO;2-T 9929100
16. The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. M Lazzarino E Orlandi F Baldanti M Furione G Pagnucco C Astori L Arcaini A Viglio M Paulli G Gerna C Bernasconi, Br J Haematol 1999 107 4 877 882 10.1046/j.1365-2141.1999.01765.x 10606897
17. Role of EBERs in the pathogenesis of EBV infection. D Iwakiri K Takada, Adv Cancer Res 2010 107 119 136 full-text 20399962
18. Epstein Barr virus (EBV)-carrying cells of a chronic lymphocytic leukemia (CLL) subpopulation express EBNA1 and LMPs but not EBNA2 in vivo. N Laytragoon-Lewin F Chen J Avila-Carino JZ Zou H Mellstedt I Ernberg G Klein, Int J Cancer 1995 63 4 486 490 10.1002/ijc.2910630404 7591254
19. Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia. JJ Tarrand MJ Keating AM Tsimberidou S O'Brien RP LaSala XY Han CE Bueso-Ramos, Cancer 2010 116 4 880 887 10.1002/cncr.24839 20052729
20. The nature of Reed-Sternberg-like cells in chronic lymphocytic leukemia. WY Tsang JK Chan C Sing, Am J Clin Pathol 1993 99 3 317 323 8447294
21. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. H Momose ES Jaffe SS Shin YY Chen LM Weiss, Am J Surg Pathol 1992 16 9 859 867 10.1097/00000478-199209000-00004 1384376
22. Epstein-Barr virus and Reed-Sternberg-like cells in chronic lymphocytic leukemia. WY Tsang JK Chan CS Ng, Am J Surg Pathol 1993 17 8 853 854 10.1097/00000478-199308000-00014 8393305
23. Implication of the Epstein-Barr virus in the progression of chronic lymphocytic leukaemia/small lymphocytic lymphoma to Hodgkin-like lymphomas. T Petrella N Yaziji F Collin G Rifle F Morlevat L Arnould P Fargeot O Depret, Anticancer Res 1997 17 5B 3907 3913 9427802
24. Hodgkin's disease variant of Richter's syndrome: experience at a single institution. L Fayad LE Robertson S O'Brien JT Manning S Wright F Hagemeister F Cabanillas MJ Keating, Leuk Lymphoma 1996 23 3-4 333 337 10.3109/ 10428199609054836 9031114
25. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype. M Vockerodt SL Morgan M Kuo W Wei MB Chukwuma JR Arrand D Kube J Gordon LS Young CB Woodman PG Murray, J Pathol 2008 216 1 83 92 10.1002/path.2384 18566961
26. Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr virus infection. D Rubin SD Hudnall A Aisenberg JO Jacobson NL Harris, Mod Pathol 1994 7 1 91 98 8159658
27. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment. DJ Shields JC Byrd SL Abbondanzo JH Lichy LF Diehl NI Aguilera, Mod Pathol 1997 10 11 1151 1159 9388067
28. Hodgkin/Reed-Sternberg cells and Hodgkin's disease in patients with B-cell chronic lymphocytic leukaemia: an immunohistological, molecular and clinical study of four cases suggesting a heterogeneous pathogenetic background. E Pescarmona P Pignoloni FR Mauro R Cerretti AP Anselmo F Mandelli CD Baroni, Virchows Arch 2000 437 2 129 132 10.1007/s004280000214 10993272
29. Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. PD Thornton C Bellas A Santon G Shah C Pocock AC Wotherspoon E Matutes D Catovsky, Leuk Res 2005 29 4 389 395 10.1016/j.leukres.2004.09.008 15725472
30. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line. Q Ren H Sato S Murono M Furukawa T Yoshizaki, Laryngoscope 2004 114 5 855 859 10.1097/00005537-200405000-00012 15126743
31. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. S Murono H Inoue T Tanabe I Joab T Yoshizaki M Furukawa JS Pagano, Proc Natl Acad Sci USA 2001 98 12 6905 6910 10.1073/pnas.121016998 11381123
32. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. H Nakagomi R Dolcetti MT Bejarano P Pisa R Kiessling MG Masucci, Int J Cancer 1994 57 2 240 244 10.1002/ijc.2910570218 8157362
33. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. L Fayad MJ Keating JM Reuben S O'Brien BN Lee S Lerner R Kurzrock, Blood 2001 97 1 256 263 10.1182/blood.V97.1.256 11133769
34. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. DF Dukers P Meij MB Vervoort W Vos RJ Scheper CJ Meijer E Bloemena JM Middeldorp, J Immunol 2000 165 2 663 670 10878338